Skip to main content
SpringerLink
Log in

Pharmacokinetic Differences between Pantoprazole Enantiomers in Rats

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Purpose

The purpose of this study was to quantitatively clarify the contribution of the absorption, protein binding, and metabolism of cytochrome P450 enzymes to the enantioselective pharmacokinetics of pantoprazole enantiomers in rats.

Methods

The enantioselective pharmacokinetics of pantoprazole enantiomers was estimated by an oral administration of racemic pantoprazole to rats. The pharmacokinetic differences between pantoprazole enantiomers were evaluated by the experiments of the in situ perfusion into rat small intestine, the protein binding, and the in vitro metabolism in rat liver microsomes of pantoprazole enantiomers.

Results

The mean area under the curve value of S-pantoprazole was 1.5 times greater than that of R-pantoprazole after administration of racemic pantoprazole to rats (20 mg/kg, p.o.). There were significant differences in ke (p < 0.05), t1/2 (p < 0.01), and mean residence time (p < 0.01) values between the two enantiomers. In the in situ absorption study, the absorption rate constants were of no significant differences between the two enantiomers. The mean unbound fraction of R-pantoprazole was slightly greater than that of S-pantoprazole. The intrinsic clearance (CLint) of the formation of the 5′-O-demethyl metabolite from S-pantoprazole was 4-fold lower than that from R-pantoprazole. However, the CLint value for the sulfone and 6-hydroxy metabolites from S-pantoprazole was higher than that from R-pantoprazole. The sum of the CLint of the formation of all three metabolites was 3.06 and 4.82 mL/min/mg protein for S- and R-pantoprazole, respectively.

Conclusions

This study suggests that the enantioselective pharmacokinetics of pantoprazole enantiomers in rats is probably ascribable to their enantioselective metabolism, which is contributed by all the three metabolic pathways, including sulfoxide oxidation, 4′-O-demethylation, and 6-hydroxylation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. P. Lindberg P. Nordberg T. Alminger A. Brandstrom B. Wallmark (1986) ArticleTitleThe mechanism of action of the gastric acid secretion inhibitor omeprazole J. Med. Chem. 29 1327–1329 Occurrence Handle10.1021/jm00158a001 Occurrence Handle3016260

    Article  PubMed  Google Scholar 

  2. A. Fitton L. Wiseman (1996) ArticleTitlePantoprazole: a review of its pharmacological properties and therapeutic use in acid-related disorders Drugs 51 460–482 Occurrence Handle8882382

    PubMed  Google Scholar 

  3. P.W. Jungnickel (2000) ArticleTitlePantoprazole: a new proton pump inhibitor Clin. Ther. 22 1268–1293 Occurrence Handle10.1016/S0149-2918(00)83025-8 Occurrence Handle11117653

    Article  PubMed  Google Scholar 

  4. W. A. Simon (1995) ArticleTitlePantoprazole—Which cytochrome P450 isoenzymes are involved in its biotransformation Gut 37 IssueIDSuppl. 2 A135

    Google Scholar 

  5. A. M. Cairns R. H. Chiou J. D. Rogers J. L. Demetriades (1995) ArticleTitleEnantioselective high-performance liquid chromatographic determination of omeprazole in human plasma J. Chromatogr. 666 323–328

    Google Scholar 

  6. G. Tybring Y. Bottiger J. Widen L. Bertilsson (1997) ArticleTitleEnantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects Clin. Pharmacol. Ther. 62 129–137 Occurrence Handle10.1016/S0009-9236(97)90060-6 Occurrence Handle9284848

    Article  PubMed  Google Scholar 

  7. M. Tanaka T. Ohkubo K. Otani A. Suzuki S. Kaneko K. Sugawara Y. Ryokawa T. Ishizaki (2001) ArticleTitleStereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin Clin. Pharmacol. Ther. 69 108–113 Occurrence Handle10.1067/mcp.2001.113723 Occurrence Handle11240974

    Article  PubMed  Google Scholar 

  8. M. Tanaka H. Yamazaki H. Hakusui N. Nakamichi H. Sekino (1997) ArticleTitleDifferential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole: a preliminary study Chirality 9 17–21 Occurrence Handle10.1002/(SICI)1520-636X(1997)9:1<17::AID-CHIR4>3.0.CO;2-D Occurrence Handle9094198

    Article  PubMed  Google Scholar 

  9. H. Katsuki H. Yagi K. Arimori C. Nakamura M. Nakano S. Katafuchi Y. Fujioka S. Fujiyama (1996) ArticleTitleDetermination of R(+)- and S(−)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans Pharm. Res. 13 611–615 Occurrence Handle10.1023/A:1016062508580 Occurrence Handle8710755

    Article  PubMed  Google Scholar 

  10. K. Kim J. Shon J. Park Y. Yoon M. Kim D. Yun M. Kim I. Cha M. Hyun J. Shin (2002) ArticleTitleEnantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19 Clin. Pharmacol. Ther. 72 90–99 Occurrence Handle10.1067/mcp.2002.126176 Occurrence Handle12152007

    Article  PubMed  Google Scholar 

  11. S. Takakuwa S. Chiku H. Nakata T. Yuzuriha N. Mano N. Asakawa (1995) ArticleTitleEnantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in Beagle dog plasma and rat plasma J. Chromatogr., B 673 113–122

    Google Scholar 

  12. N. Mano Y. Oda S. Takakuwa S. Chiku H. Nakata N. Asakawa (1996) ArticleTitlePlasma direct injection high-performance liquid chromatographic method for simultaneous determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column J. Pharm. Sci. 85 903–907 Occurrence Handle10.1021/js960172n Occurrence Handle8877876

    Article  PubMed  Google Scholar 

  13. A. Abelo T. B. Andersson M. Antonsson A. K. Naudot I. Skanberg L. Weidolf (2000) ArticleTitleStereoselective metabolism of omeprazole by human cytochrome P450 enzymes Drug Metab. Dispos. 28 966–972 Occurrence Handle10901708

    PubMed  Google Scholar 

  14. K. Arimori K. Yasuda H. Katsuki M. Nakano (1998) ArticleTitlePharmacokinetic differences between lansoprazole enantiomers in rats J. Pharm. Pharmacol. 50 1241–1245 Occurrence Handle9877309

    PubMed  Google Scholar 

  15. K. Masa A. Hamada K. Arimori J. Fujii M. Nakano (2001) ArticleTitlePharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs Biol. Pharm. Bull. 24 274–277 Occurrence Handle10.1248/bpb.24.274 Occurrence Handle11256484

    Article  PubMed  Google Scholar 

  16. K. A. Kim M. J. Kim J. Y. Park J. H. Shon Y. R. Yoon S. S. Lee K. H. Liu J. H. Chun M. H. Hyun J. G. Shin (2003) ArticleTitleStereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes Drug Metab. Dispos. 31 1227–1234 Occurrence Handle10.1124/dmd.31.10.1227 Occurrence Handle12975331

    Article  PubMed  Google Scholar 

  17. A. Abelo T. B. Andersson U. Bredberg I. Skanberg L. Weidolf (2000) ArticleTitleStereoselective metabolism by human liver CYP enzymes of a substituted benzimidazole Drug Metab. Dispos. 28 58–64 Occurrence Handle10611141

    PubMed  Google Scholar 

  18. N. Masubuchi H. Yamazaki M. Tanaka (1998) ArticleTitleStereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats Chirality 10 747–753 Occurrence Handle10.1002/(SICI)1520-636X(1998)10:8<747::AID-CHIR5>3.0.CO;2-B Occurrence Handle9803530

    Article  PubMed  Google Scholar 

  19. H. Hirayama X. Xu K. S. Pang (1989) ArticleTitleViability of the vascularly perfused, recirculating rat intestine and intestine–liver preparations Am. J. Physiol. 257 G249–G258 Occurrence Handle2764110

    PubMed  Google Scholar 

  20. L. Ernster P. Siekevitz G. E. Palada (1962) ArticleTitleEnzyme–structure relationships in the endoplasmic reticulum of rat liver J. Cell Biol. 15 541–562 Occurrence Handle10.1083/jcb.15.3.541

    Article  Google Scholar 

  21. O. H. Lowry N. J. Rosebrough A. L. Farr R. J. Randall (1951) ArticleTitleProtein measurement with the folin phenol reagent J. Biol. Chem. 193 175–265 Occurrence Handle14907703

    PubMed  Google Scholar 

  22. K. Yanaoka Y. Tanigawara T. Nakagawa T. Iga (1981) ArticleTitleA pharmacokinetic analysis program (MULTI) for microcomputer J. Pharmacobio-Dyn. 4 879–885 Occurrence Handle7328489

    PubMed  Google Scholar 

  23. D. F. Zhong Z. Y. Xie X. Y. Chen (2005) ArticleTitleMetabolism of pantoprazole involving conjugation with glutathione in rats J. Pharm. Pharmacol. 57 341–349 Occurrence Handle10.1211/0022357055669 Occurrence Handle15807990

    Article  PubMed  Google Scholar 

  24. Z. Y. Xie B. H. Yang Y. F. Zhang D. F. Zhong (2004) ArticleTitleStudies on chiral inversion of dextro-pantoprazole in human Acta Pharm. Sin. 39 370–373

    Google Scholar 

  25. N. Mano Y. Oda S. Takakuwa T. Yuzuriha N. Mano N. Asakawa (1996) ArticleTitlePlasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column J. Pharm. Sci. 85 903–907 Occurrence Handle10.1021/js960172n Occurrence Handle8877876

    Article  PubMed  Google Scholar 

  26. H. Stenhoff A. Blomqvist P. O. Lagerstrom (1999) ArticleTitleDetermination of the enantiomers of omeprazole in blood plasma by normal-phase liquid chromatography and detection by atmospheric pressure ionization tandem mass spectrometry J. Chromatogr., B 734 191–201

    Google Scholar 

  27. R. Huber B. Kohl G. Sachs J. Senn-Bilfinger W. A. Simon E. Sturm (1995) ArticleTitleThe continuing development of proton pump inhibitor, with particular reference to pantoprazole Aliment. Pharmacol. Ther. 9 363–378 Occurrence Handle8527612

    PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported in part by Grant 2003AA2Z347C of the “863” Program of China.

Author information

Authors and Affiliations

  1. Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, People's Republic of China

    Zhiyong Xie, Yini Zhang, Haiyan Xu & Dafang Zhong

Authors
  1. Zhiyong Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yini Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haiyan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dafang Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dafang Zhong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, Z., Zhang, Y., Xu, H. et al. Pharmacokinetic Differences between Pantoprazole Enantiomers in Rats. Pharm Res 22, 1678–1684 (2005). https://doi.org/10.1007/s11095-005-6807-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-005-6807-x

Key words

Search

Navigation